COVID-19 and diabetes: Knowledge in progress
Top Cited Papers
Open Access
- 9 April 2020
- journal article
- review article
- Published by Elsevier BV in Diabetes Research and Clinical Practice
- Vol. 162, 108142
- https://doi.org/10.1016/j.diabres.2020.108142
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Glycolytic control of vacuolar-type ATPase activity: A mechanism to regulate influenza viral infectionVirology, 2013
- High glucose disrupts oligosaccharide recognition function via competitive inhibition: A potential mechanism for immune dysregulation in diabetes mellitusImmunobiology, 2011
- Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseasesArthritis & Rheumatism, 2010
- Binding of SARS coronavirus to its receptor damages islets and causes acute diabetesActa Diabetologica, 2009
- Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumoniaEuropean Respiratory Journal, 2008
- SARS: Systematic Review of Treatment EffectsPLoS Medicine, 2006
- Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARSDiabetic Medicine, 2006
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injuryNature Medicine, 2005
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003
- Immune dysfunction in patients with diabetes mellitus (DM)FEMS Immunology & Medical Microbiology, 1999